Fagan Associates Inc. purchased a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,395 shares of the healthcare conglomerate’s stock, valued at approximately $371,000.

Several other hedge funds have also recently made changes to their positions in UNH. Welch Group LLC bought a new stake in UnitedHealth Group during the 2nd quarter worth about $106,000. FNY Investment Advisers LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $106,000. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the 2nd quarter worth about $107,000. Fort L.P. bought a new stake in UnitedHealth Group during the 2nd quarter worth about $119,000. Finally, Polaris Greystone Financial Group LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $120,000. 85.45% of the stock is owned by institutional investors.

UNH has been the topic of several analyst reports. Citigroup cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price target on the stock. in a research report on Monday, September 10th. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Raymond James boosted their price target on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Bank of America boosted their price target on shares of UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research report on Wednesday, October 17th. Finally, Morgan Stanley boosted their price target on shares of UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. One analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $289.41.

Shares of UNH stock opened at $266.05 on Tuesday. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $260.82 billion, a PE ratio of 26.42, a PEG ratio of 1.56 and a beta of 0.78. UnitedHealth Group Inc has a 52-week low of $208.48 and a 52-week high of $278.00.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. UnitedHealth Group’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.66 EPS. As a group, equities analysts forecast that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be issued a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is 35.75%.

In other news, CEO Steven H. Nelson sold 26,033 shares of the company’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $270.65, for a total value of $7,045,831.45. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP D Ellen Wilson sold 15,393 shares of the stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the completion of the transaction, the executive vice president now directly owns 66,402 shares in the company, valued at $17,549,384.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 69,731 shares of company stock worth $18,584,675. 0.87% of the stock is owned by insiders.

WARNING: “1,395 Shares in UnitedHealth Group Inc (UNH) Acquired by Fagan Associates Inc.” was published by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/11/20/1395-shares-in-unitedhealth-group-inc-unh-acquired-by-fagan-associates-inc.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Why is insider trading harmful?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.